Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2012

Dec 4, 2012

29777_dirs_2012-12-04_2689db33-0611-4ca3-b761-738429060eda.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-12-01

Reporting Person: ALBAN CARLOS (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-11-16 Common shares without par value G 40442 Disposed 77243 Direct
2012-12-01 Common shares without par value A 18453 Acquired 95696 Direct
2012-11-16 Common shares without par value G 40442 Acquired 40442 Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards will cliff vest after January 1, 2016, subject to AbbVie reaching a minimum average return on equity target for the period 2013 through 2015. The awards include the right to have stock withheld for tax purposes.

F2: Held in the Maria Cristina Alban 2007 Declaration of Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.